Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT00635791
Show Display Options
RSS Create an RSS feed from your search for:
NCT00635791
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
Conditions: Malignant Solid Tumour;   Renal Cell Carcinoma;   Non Small Cell Lung Carcinoma
Interventions: Drug: Sorafenib;   Drug: Vorinostat

Study has passed its completion date and status has not been verified in more than two years.